Patent · US Active

Kiwi extract

US7862840B2 · kind B2 · utility

2Cited by
16References
14Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 26, 2007
Grant dateJan 4, 2011
Priority date
Expiry dateNov 7, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention describes the preparation, isolation and use of an extract of kiwi fruit for the treatment of a disease or condition related with, caused by or mediated by activity of human pancreatic lipase and/or human fatty acid synthase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.